Microbially derived (γ-PGA) poly-γ-glutamic acid: applications and commercial uses across industries

spp., with reported production yields ranging from 10-115 g/L depending on the strain, substrate, and fermentation conditions. Recent advancements (2020-2024) in microbial engineering, fed-batch optimization, and low-cost agro-residue substrates have significantly improved γ-PGA productivity, reduced downstream processing costs by 15-30%, and enabled the development of high-purity (>90%) fractions suitable for food, pharmaceutical, and biomedical applications. Unlike earlier reviews that primarily catalog applications, the present work provides a cross-sector comparative analysis integrating (1) strain-specific production efficiency, (2) molecular-weight-dependent functional performance, and (3) quantitative application outcomes such as 2-7-fold enhancement in mineral absorption, 40-60% increase in water retention for agricultural soils, and up to 85% reduction in cytotoxicity in biomedical formulations. This review further assesses emerging technologies, such as membrane-assisted purification, genome-edited Bacillus strains, and smart delivery systems; it critically evaluates regulatory challenges, commercial readiness levels, and market trajectories. This review, through the integration of recent data and industrial trends, identifies the major bottlenecks and opportunities that require further research to place γ-PGA as a scalable, microbially sourced, green polymer with high potential for the next-generation sectors biotechnological-driven.